PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PLACENTAL EXTRACTS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29Linked to original sources

Similar control mechanisms regulate the insulin and type I insulin-like growth factor receptor kinases. Affinity-purified insulin-like growth factor I receptor kinase is activated by tyrosine phosphorylation of its beta subunit.

Insulin-like growth factor I (IGF-I) receptors are partially purified from human placenta by sequential affinity chromatography with wheat germ agglutinin-agarose and agarose derivatized with an IGF-I analog. Adsorption specificity to this affinity matrix demonstrates that low coupling ratios of IGF-I analog to agarose yield preparations that are highly selective in purifying IGF-I receptor with minimal cross-contamination by the insulin receptor present in the same placental extracts. Incubation of the immobilized IGF-I receptor preparation with [gamma-32P]ATP results in a marked phosphorylation of the receptor beta subunits, which appear as a doublet of Mr = 93,000 and 95,000 upon electrophoresis on dodecyl sulfate-polyacrylamide gels. The 32P-labeled receptor beta subunit doublet contains predominantly phosphotyrosine and to a much lesser extent phosphoserine and phosphothreonine residues. The immobilized IGF-I receptor preparation exhibits tyrosine kinase activity toward exogenous histone. The characteristics of the IGF-I receptor-associated tyrosine kinase are remarkably similar to those of the insulin receptor kinase. Thus, prior phosphorylation of the immobilized IGF-I receptor preparation with increasing concentrations of unlabeled ATP followed by washing to remove the unreacted ATP results in a progressive activation of the receptor-associated histone kinase activity. A maximal (10-fold) activation is achieved between 0.25 and 1 mM ATP. The concentration of ATP required for half-maximal (30 microM) activation of the IGF-I receptor kinase is similar to that of the insulin receptor kinase. Like the insulin receptor kinase, the elevated kinase activity of the phosphorylated IGF-I receptor is reversed following dephosphorylation of the receptor beta subunit with alkaline phosphatase. Furthermore, the phosphorylation of the IGF-I receptor beta subunit doublet is enhanced by 7-8-fold when reductant is included in the reaction medium, as is observed for the insulin receptor kinase. Significantly, the dose responses of both receptor types to reductant are identical. Both of the 32P-labeled IGF-I receptor beta subunit bands are resolved into six matching phosphopeptide fractions when the corresponding tryptic hydrolysates are resolved by reverse phase high pressure liquid chromatography. Significantly, four out of the six phosphopeptide fractions derived from the trypsinized IGF-I receptor beta subunits are chromatographically identical to those from the tryptic hydrolysates of 32P-labeled insulin receptor beta subunit.(ABSTRACT TRUNCATED AT 400 WORDS)

Adsorption↗

[Gonadotropic activity of the immunoglobulins from placental, abortion and donor blood].

Gonadotropic activity of 106 series of immunoglobulin preparations obtained in the USSR and-the People's Republic of Bulgaria was studied. In difference from donor immunoglobulins, all the preparations of placental materials were contaminated with chorionic gonadotropin. Gonadotropin content in the immunoglobulins made of abortion serum was 2--7 times greater than in the preparations from the retoplacental serum and the placental extracts. The mean results of gonadotropin content in the immunoglobulins obtained by biological studies differed from those obtained from the investigations by immunological methods since the mentioned methods apparently characterized different properties of the hormonal molecule.

Abortion, Spontaneous↗

Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation.

Transamidases are enzymes, which are necessary for normal clot formation. They fall into two types: thrombin-dependent Factor XIII and thrombin-independent tissue transglutaminases. The investigation showed that human placenta contains not only Factor XIII, but also considerable amounts of a tissue trans-glutaminase identical with an enzyme present in red blood cells. A quantitative assay for transamidases, using incorporation of radioactively labelled putrescine into casein, was applied to placental extracts. With this assay the amounts of thrombin-dependent and thrombin-independent transamidases were determined in the placenta of fullterm infants and term infants who were small for gestational age. The transamidase activities of the placenta in the two groups showed no statistically significant difference. Plasma Factor XIII subunit a antigen concentration was increased by about 40% in midpregnancy and returned to normal nonpregnant values in the 3rd trimester, but when intrauterine growth was retarded the plasma Factor XIII concentration remained elevated. Plasma Factor XIII activities showed a similar variation.

Factor XIII↗

Tumor and placental histaminase, II A procedure for radioimmunoassay.

Histaminase (diamine oxidase) is an enzyme associated with pregnancy and with a number of human cancers. In pregnancy, the enzyme is produced by the decidual cells of the placenta. Histaminase of the placenta is biochemically and immunologically identical to that of cancer, Based on this, a radioimmunoassay procedure for histaminase has been developed. The high affinity monospecific antiserum for the assay was obtained from rabbits by injecting with homogeneous histaminase purified from placenta by affinity chromatography. Radioactive labeling of histaminase was carried out by iodination with 125I using chloramine T as the oxidizing agent. The iodination yielded [125I]-histamine of high specific radioactivity (20 microCi/microgram protein) with no apparent affect on the immunologic affinity. For separating the antibody-antigen complex from the unbound antigen, a second antibody bound to polyacrylamide beads was most effective at high antiserum dilutions. The assay had a working range of 0.3 to 80 microgram/ml and a minimal detectable quantity of 0.15 ng/ml. Compared to the enzymatic assay with [14C] putrescine as substrate, the radioimmunoassay procedure is about 70 times more sensitive. Measurements of histamine in placental extracts and malignant effusions using both radioimmunoassay and enzyme assay demonstrated that the two methods were highly correlated, thus providing evidence for the specificity of the radioimmunoassay. This procedure will be useful in future studies of histaminase as a biochemical marker for human cancer and for the elucidation of the significance of this enzyme is pregnancy and in neoplasia.

Amine Oxidase (Copper-Containing)↗

[Trophoblastic beta 1-glycoprotein in the blood in trophoblastic tumors].

Trophoblastic beta 1-glycoprotein (TBG) or a "specific protein of pregnancy" isolated from placental extracts and retroplacental serum, is a reliable marker of trophoblastic tumors. A highly sensitive quantitative radioimmunoassay to determine TBG was developed. The use of this method in the Department of Gynecology. All-Union Cancer Research Center, USSR AMS, for a dynamic observation over patients with different trophoblastic tumors for 3 yrs. has shown that TBG is determined in 94.7% of the cases, this antigen concentration correlating with the disease stage and reflecting a clinical course of the disease. Chorionic gonadotropin (CG) determined simultaneously in the urine of the same patients, was found in 84% of the cases. TBG indices correlate with the CG level in 75% of the cases and serve as an important criterion in the diagnosis and evaluation of efficacy of treatment provided to patients with trophoblastic tumors.

Adult↗

[Isolation and purification of placental coagulation inhibitor].

The placenta contains such thrombotic factors as tissue thromboplastin, placental factor XIII, and placental urokinase inhibitor. On the other hand, there are some antithrombotic factors, for example, placental plasminogen activator and platelet aggregation inhibitor. This paper deals with another antithrombotic factor isolated from the human placenta. The results obtained are as follows: The placental coagulation inhibitor (PCI) was isolated from the human placental extract, by delipidation and chromatographic procedures with Con-A Sepharose, DEAE-Sephacel and gel filtration with Sephacryl S-300 and Sephadex G-100. The PCI was a protein, having a molecular weight of approximately 45,000 daltons. Immunological examination revealed that the PCI was different from such well-known anticoagulants as AT-III, alpha 1-AT, alpha 2-M, C1-INA, and the PCI had no heparin like characteristics. The PCI had neither fibrinolytic nor antifibrinolytic activity. Platelet aggregation was not inhibited by the PCI. The PCI had anticoagulant activity which prolongs both intrinsic and extrinsic coagulation systems.

Anticoagulants↗

Tumor and placental histaminase, I. affinity chromatography purification and characterization of the placental enzyme.

Histaminase (diamine oxidase) is an enzyme produced at very high levels by the decidua of the placenta and is found to be associated with a number of human cancers. A procedure for the affinity chromatography purification of this enzyme is described. In this procedure, cadaverine-AH-sepharose was used to bind the enzyme in the placental extract. After extensive washing of the column with 2.5% Triton X-100 in 1 M NaCl, the enzyme was released from the column by 0.1 N chromotropic acid. This purification, essentially a one step procedure, provided 1800-fold purification, and yielded mg quantities of histaminase, homogeneous by SDS-gel electrophoresis and immunodiffusion tests. The procedure usually recovered more than 40% of the enzyme applied and the specific activity of the final enzyme preparation was around 5000 units/mg protein. SDS-gel electrophoresis of the enzyme in different concentrations of acrylamide indicated that the subunit molecular weight of histaminase was about 90,000. Isoelectric focusing of the enzyme in polyacrylamide gel revealed 5 major enzyme components. Results of amino acid analyses indicated that the enzyme had a low content of sulfur-containing amino acids and a relatively high content of dicarboxylic amino acids. The availability of this purification will be useful for the development of immunological methods for detections and quantitation of this enzyme in specimens from cancer patients.

Amine Oxidase (Copper-Containing)↗

Pregnancy-specific beta 1-glycoprotein (SP1). Purification and partial characterization.

The pregnancy-specific beta 1-glycoprotein, SP1, was purified to homogeneity from placental extract and from serum using immunoadsorbent techniques. The isolated SP1 had a molecular weight of 90,000-110,000 daltons and an amino acid and amino sugar composition typical of an acidic glycoprotein. The availability of purified SP1 will be of value in the further evaluation of the role and importance of SP1 in malignancies as well as in normal development.

Amino Acids↗

Toxemia of pregnancy. Part II. Immunofluorescent studies with placental connective tissue antisera: the possibility of characteristic lesions.

Seventeen placentas from term gestation complicated by toxemia of pregnancy and 17 normal controls were tested by the fluorescent antibody technic. Antisera to normal placental connective tissue and toxemic placental connective tissue were used. The antisera were obtained by the injection into rabbits of placental extracts rich in connective tissue elements from normal and toxemic placentas. The antitoxemic antisera, after absorption with soluble sonic fraction of normal placentas, stained the following elements exclusively in 14 of the 17 placentas: part of the syncytial knots, fibrillar elements in the adventitia of blood vessels, and amorphous deposition of connective tissue. In each of the remaining three placentas at least two of the lesions were observed. The observation of bright fluorescence in part of the syncytiotrophoblasts and the syncytial knots in toxemic placentas led to the suggestion that they arise late in pregnancy during the disease. The thin fibrillar elements and the amorphous deposition of connective tissue were documented in the various developmental stages in toxemic and normal placentas as well. These findings established possible characteristic lesions in the placenta of pregnancies complicated by toxemia.

Adolescent↗

[Evidence for and assay of a chorionic gonadotropin in the rat (rCG)].

A sensitive radioreceptorassay for human and animal gonadotropins made it possible to demonstrate and quantitate a Rat chorionic gonadotropin (rCG) in placental extracts and amniotic fluid. rCG appears as soon as day 8 and concentration is maximum at day 13 of gestation. This hormone might be the major ovarian stimulatory factor during mid gestation period.

Amniotic Fluid↗

Increased serum gastrin concentrations and gastric acid hyposecretion in the immediate newborn period.

Thirty-two infants and their mothers were studied to determine the source of elevated serum gastrin concentrations in umbilical blood and to learn whether neonates hypersecreted acid in response to hypergastrinemia. Gastrin concentrations in the umbilical artery and vein were similar. Both were significantly higher than maternal gastrin concentrations. No significant amount of gastrin could be measured in placental extracts. These results suggest that the increased neonatal gastrin concentrations were fetal in origin. Continuous basal acid secretory studies done for 4 hr in 32 infants and for 8 hr in 9 infants demonstrated hyposecretion of gastric acid for the first 5 hr of life. Acid secretion from hour 6 to 8 was similar to that in older children. Increased gastrin levels were still present at hour 8 and were associated with normal gastric acid secretion.

Fetal Blood↗

[Comparative study of the content of blood group substances A and B in immunoglobulins prepared from placental and donor sera].

Blood group specific substances A and B were revealed in all the samples of immunoglobulin commercial preparations made in the USSR, Bulgaria, and India from the retroplacental, abortion sera, and from the placental extract. Their content varied in different batches of the preparations--from 8 to 64 microgram/ml of substance A, and from 6 to 256 microgram/ml of substance B. In the majority of immunoglobulin batches prepared from donor sera no group-specific blood substances A and B were revealed; only in 3 of 14 batches was there revealed substance A in the amount of 3 microgram/ml.

ABO Blood-Group System↗

Effect of placental soluble factors on growth and differentiation of mouse ectoplacental cone in vitro.

The effect of soluble fractions derived from the placenta on the outgrowth and giant cell transformation of the ectoplacental cone (EPC) was investigated in vitro. EPCs taken from the fetal mice on day 7.5 post coitum (pc) were incubated with alpha-MEM-containing fetal calf serum (FCS) (FCS-alpha-MEM) for 24 hr. Then, the medium was exchanged with alpha-MEM alone, FCS-alpha-MEM, or alpha-MEM containing a crude extract from placental region on day 8.5, 10.5 or 12.5 pc (10 ml phosphate buffer/g placenta). Each EPC was continued to be incubated for 6 days, and the rate of EPC outgrowth and the number of trophoblastic giant cells (TGCs) were evaluated under a phase-contrast microscope. As a result, the administration of each placental extract significantly induced the cell spreading and TGC transformation of EPC as compared with the culture in alpha-MEM alone. The rate of cell-spreading rapidly increased on the 2nd day after incubation in the medium containing placental extracts. In particular, EPC outgrowth was more remarkable in the medium containing the 10.5-day placental extract than in the other media including FCS-containing medium. The number of transformed TGCs was also the largest in the 10.5-day medium among the groups examined. These results indicate that certain placental factors at mid-gestation, especially on day 10.5 pc, may facilitate the EPC differentiation.

Animals↗